Jessica Theißen

3.5k total citations
15 papers, 754 citations indexed

About

Jessica Theißen is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Jessica Theißen has authored 15 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Jessica Theißen's work include Neuroblastoma Research and Treatments (14 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Jessica Theißen is often cited by papers focused on Neuroblastoma Research and Treatments (14 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Jessica Theißen collaborates with scholars based in Germany, France and United States. Jessica Theißen's co-authors include Frank Berthold, Matthias Fischer, Barbara Hero, Frank Westermann, Benedikt Brors, André Oberthuer, Volker Ehemann, Frederik Roels, Yvonne Kahlert and Sandra Ackermann and has published in prestigious journals such as Nature, Bioinformatics and Oncogene.

In The Last Decade

Jessica Theißen

15 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jessica Theißen Germany	12	515	441	377	153	59	15	754
Zaowen Chen United States	13	475 0.9×	396 0.9×	298 0.8×	312 2.0×	56 0.9×	15	745
Kai-Oliver Henrich Germany	9	361 0.7×	319 0.7×	208 0.6×	135 0.9×	66 1.1×	12	550
Susanne Fransson Sweden	15	359 0.7×	309 0.7×	183 0.5×	126 0.8×	34 0.6×	38	542
Rose‐Marie Sjöberg Sweden	15	414 0.8×	399 0.9×	267 0.7×	141 0.9×	24 0.4×	16	629
Katarina Ejeskär Sweden	16	400 0.8×	223 0.5×	188 0.5×	125 0.8×	44 0.7×	35	593
Jayanti Jagannathan United States	5	426 0.8×	374 0.8×	226 0.6×	153 1.0×	24 0.4×	6	605
Mark W. Zimmerman United States	12	530 1.0×	319 0.7×	170 0.5×	121 0.8×	86 1.5×	24	706
Theresa Thor Germany	8	558 1.1×	243 0.6×	214 0.6×	100 0.7×	52 0.9×	12	710
Anna Djos Sweden	13	330 0.6×	317 0.7×	175 0.5×	126 0.8×	17 0.3×	24	491
Hisanori Takenobu Japan	13	340 0.7×	174 0.4×	147 0.4×	266 1.7×	103 1.7×	25	616

Countries citing papers authored by Jessica Theißen

Since Specialization

Citations

This map shows the geographic impact of Jessica Theißen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Theißen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Theißen more than expected).

Fields of papers citing papers by Jessica Theißen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Theißen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Theißen. The network helps show where Jessica Theißen may publish in the future.

Co-authorship network of co-authors of Jessica Theißen

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Theißen. A scholar is included among the top collaborators of Jessica Theißen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Theißen. Jessica Theißen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Theißen, Jessica, et al.. (2018). Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines. Experimental Cell Research. 375(2). 92–99. 23 indexed citations

Hero, Barbara, Nathalie Clément, Ingrid Øra, et al.. (2017). Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome. Journal of Pediatric Hematology/Oncology. 40(2). 93–98. 7 indexed citations

Powers, John T., Kaloyan M. Tsanov, Daniel S. Pearson, et al.. (2016). Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature. 535(7611). 246–251. 138 indexed citations

Ackermann, Sandra, Barbara Hero, Volker Ehemann, et al.. (2014). FOXP1inhibits cell growth and attenuates tumorigenicity of neuroblastoma. BMC Cancer. 14(1). 840–840. 24 indexed citations

Theißen, Jessica, André Oberthuer, Ruth Volland, et al.. (2014). Chromosome 17/17q gain and unaltered profiles in high resolution array‐CGH are prognostically informative in neuroblastoma. Genes Chromosomes and Cancer. 53(8). 639–649. 27 indexed citations

Ackermann, Sandra, Barbara Hero, Yvonne Kahlert, et al.. (2013). Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death and Disease. 4(4). e586–e586. 159 indexed citations

Dreidax, Daniel, Christina I. Schroeder, Daniel Muth, et al.. (2013). Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis. Human Molecular Genetics. 22(9). 1735–1745. 10 indexed citations

Toloşi, Laura, et al.. (2013). A method for finding consensus breakpoints in the cancer genome from copy number data. Bioinformatics. 29(14). 1793–1800. 6 indexed citations

Coco, Simona, Jessica Theißen, Paola Scaruffi, et al.. (2012). Age‐dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma. International Journal of Cancer. 131(7). 1591–1600. 45 indexed citations

10.

Stigliani, Sara, Simona Coco, Stefano Moretti, et al.. (2012). High Genomic Instability Predicts Survival in Metastatic High-Risk Neuroblastoma. Neoplasia. 14(9). 823–IN10. 40 indexed citations

11.

Schulte, Johannes H., Hagen S. Bachmann, Katleen De Preter, et al.. (2011). High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma. Clinical Cancer Research. 17(15). 5082–5092. 72 indexed citations

12.

Afanasyeva, Elena, Pieter Mestdagh, Candy Kumps, et al.. (2011). MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival. Cell Death and Differentiation. 18(6). 974–984. 128 indexed citations

13.

Theißen, Jessica, Ruediger Spitz, David R. Betts, et al.. (2009). Heterogeneity of the MYCN Oncogene in Neuroblastoma. Clinical Cancer Research. 15(6). 2085–2090. 37 indexed citations

14.

Fischer, Matthias, Tobias Bauer, André Oberthür, et al.. (2009). Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q. Oncogene. 29(6). 865–875. 23 indexed citations

15.

Oberthuer, André, Jessica Theißen, Frank Westermann, Barbara Hero, & Matthias Fischer. (2009). Molecular Characterization and Classification of Neuroblastoma. Future Oncology. 5(5). 625–639. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact